Fundz

Who to call at Omeros Corporation, and when

Fundz watches for the moments Omeros Corporation starts buying, and tells you who to reach.

  • An alert the day Omeros Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Omeros Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Omeros Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Omeros Corporation

A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.

www.omeros.com
Filed: Oct 30, 2026SeattleCIK: 0001285819Health Care
Full company profileView on SEC.gov

Executive Summary

Analysis of 8-K filing content

Omeros Corporation granted CEO Gregory A. Demopulos a performance-based stock option award for 500,000 shares with an exercise price of $17.88, vesting based on stock price hurdles ($25–$40) and continued service through October 2031. The award recognizes his role in achieving FDA approval for YARTEMLEA and executing strategic transactions in 2025.

Quick answer

Omeros Corporation filed a Form 8-K with the SEC on October 30, 2026 under Item 5.02 (Executive Change). Omeros Corporation granted CEO Gregory A. Demopulos a performance-based stock option award for 500,000 shares with an exercise price of $17.88, vesting based on stock price hurdles ($25–$40) and continued service through October 2031.

What did Omeros Corporation disclose in its 8-K filed October 30, 2026?
Omeros Corporation granted CEO Gregory A. Demopulos a performance-based stock option award for 500,000 shares with an exercise price of $17.88, vesting based on stock price hurdles ($25–$40) and continued service through October 2031. The award recognizes his role in achieving FDA approval for YARTEMLEA and executing strategic transactions in 2025.
What does 8-K Item 5.02 (Executive Change) mean?
A senior executive or director joined, left, or changed roles. Companies generally must file it within four business days of the event.
Which other companies filed an 8-K Item 5.02 around the same time?
Utz Brands, Inc. (October 30, 2026), LiveOne, Inc. (October 30, 2026), Jaguar Uranium Corp. (October 30, 2026) and PodcastOne, Inc. (October 30, 2026) also filed an Item 5.02 8-K within a week of Omeros Corporation.
Where can I read the original Omeros Corporation filing?
The original filing is on SEC EDGAR (CIK 0001285819), accession number 0001552781-26-000531.

Source: Fundz verified event record.

Other companies that filed an 8-K Item 5.02 (Executive Change) the same week

Analyzed filings with the same item number within 7 days, from SEC EDGAR via Fundz.

  • Utz Brands, Inc. (October 30, 2026): Utz Brands, Inc. is being acquired by Idaho USA, Inc. and will become an indirect wholly-owned subsidiary of Intersnack Group GmbH & Co. KG as part of a strategic transition to...
  • LiveOne, Inc. (October 30, 2026): Craig Christensen, LiveOne's Interim CFO, Treasurer, Secretary, and acting principal accounting officer, is departing the company effective October 30, 2026, to pursue another...
  • Jaguar Uranium Corp. (October 30, 2026): Jaguar Uranium Corp. appointed three new executives and granted them stock options totaling 725,000 shares on October 29, 2026, as part of a long-term incentive plan to align...
  • PodcastOne, Inc. (October 30, 2026): PodcastOne's Interim CFO Craig Christensen departed effective October 30, 2026, to pursue another professional opportunity.
  • GridAI Technologies Corp. (October 30, 2026): GridAI Technologies appointed Anna Skowron as Interim CFO effective September 1, 2026, under an amended consulting agreement with a $27,000 monthly retainer and up to 250,000 RSUs...
  • Visium Technologies, Inc. (October 30, 2026): Paul R. Taylor resigned as Chairman, CEO, and director of Visium Technologies effective October 26, 2026, after serving only six months.

Key Takeaways

Performance-based option grant of 500,000 shares to CEO with exercise price of $17.88 per share, representing significant upside potential if stock price targets are met

Vesting tied to four stock price hurdles (40%, 68%, 96%, and 124% appreciation above grant price) plus time-based service conditions over 48 months

2 more takeaways

Related Filings (1)

1 more filing from Omeros Corporation in the last 90 days

Filing Overview

Form Type8-K
Filing DateOct 30, 2026
Item5.02
CategoryExecutive Change
CIK0001285819
Accession #0001552781-26-000531
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
other

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings

Omeros Corporation filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.